Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).
about
Immunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intentClinical Translation of Nanomedicine.Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data BaseBronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital.Lung cancer: current diagnosis and treatmentINSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancerUsing pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review.Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factorsPulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and LeukemiEnhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancerComplex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathwaysInduction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer.Caveolins and lung functionRadiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor MicroenvironmentDNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer.Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinomaNanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimenCombination of radiotherapy and chemotherapy in locally advanced NSCLC.Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer.Lung cancer staging: an overview of the new staging system and implications for radiographic clinical stagingInoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine.Proton beam therapy for locally advanced lung cancer: A review.Robotic-Assisted Thoracic Surgery for Early-Stage Lung Cancer: A Review.Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer.Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease.Normal lung sparing Tomotherapy technique in stage III lung cancer.Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients.US-guided core-needle biopsy versus US-guided fine-needle aspiration of suspicious cervical lymph nodes for staging workup of non-head and neck malignancies: A propensity score matching study.Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer.Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.Non-conventional radiotherapy versus conventional radiotherapy for inoperable non-small-cell lung cancer: A meta-analysis of randomized clinical trials.DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer.
P2860
Q24194081-649907FC-A31F-4322-8851-773912082009Q30355939-E6FEE3CE-5770-40CE-8C53-F9BB195FFE6BQ30702531-1E607E42-F69A-4E8C-8A0C-2D92E5968A7CQ33517827-6513FB06-66F3-40D0-BBEE-9BB9EE8EBCCCQ33554085-D53E66E5-ECEF-440A-88D9-A565D48FEC2AQ34044082-06765EB6-70BC-4BD7-87C5-032AABA9D5A5Q34637882-A05D2C5D-1896-445F-A5C2-2DA08CA75D93Q35062350-8513691F-70AD-4038-BB07-4A3FBFF25FF9Q35103355-E31B3712-0A05-47EF-BB8A-BE32E4713F09Q35269285-31FBBE72-2782-4E9B-A631-FA820981F6A6Q36051715-C6A52FFA-76DC-46D3-8894-4B99558D153DQ36097945-1B386300-490D-44A9-91EA-7CE9D1D187BAQ36113767-131D628E-149C-4326-BAA2-612F711ACBDFQ36253530-12D94635-1F2B-4993-B167-F13E97184C49Q36325572-F46B0F93-624A-46D0-B1F7-943AD0BC76EBQ36384058-CEE0A5EB-CCDF-4226-B84C-32EAB5A01AFBQ36603426-750C8B3B-9857-4A97-BAAD-6851AFC74FD7Q36855596-88C5B8BD-FB60-47E7-BCCE-F0D31FE6D94DQ36859958-E461408E-4DFA-4D93-88BC-99899FD2BA5BQ36860835-D0ABBB03-CF8D-4BD8-BCE8-DEF5A51AF907Q37111842-770B7666-1C2F-424C-B092-59D884C3F77EQ37614572-3DD31606-E199-4FE0-AA8D-01CEE5A97867Q37853481-FF4E8872-591D-414D-9C7E-C1F7AC32444BQ37897353-E71160A5-13F3-4D4C-BA64-45850E181CC4Q37977438-622BCB5D-365F-40CF-B240-F328B271E416Q38258751-D5560705-02CB-4FC6-A423-511894507868Q38539574-F62F0143-F5C0-439C-831D-77E9407EC507Q38925887-15467A96-8674-44CD-95B7-D46F817F36F6Q39803701-C35D85BB-9D70-4E2A-BE53-F92E844C1625Q40585488-FE403595-B29E-4740-9F23-8CCDC990F412Q43561521-4009356F-0F86-4FE3-9D09-A333842033A7Q44174829-09ED3465-FCBD-4FE0-8913-2B645B0069BAQ44401905-1FD1B33C-5E41-4F86-9EEA-8B71F1BB475AQ47116760-AA1E3BA5-103B-46AB-9876-12F92D2AE6CCQ47150627-C538070C-1CC3-4679-8A8E-A25E733826DDQ48222591-0D3CD160-7510-4B92-B1E2-2C0A0D6C2DFCQ48353696-1C3E4835-32CB-4E74-BC16-D8DE83D5EE9EQ50046179-0A807ABD-908A-419E-8869-3997ECE7FCE1Q50050164-A8EBA9DC-2559-4EB4-9E7A-0CEB7D86742AQ55506344-E4BE7015-ACF8-4EC1-A535-B167C58E03C1
P2860
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
type
label
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
prefLabel
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
P2093
P356
P1433
P1476
Treatment of non-small cell lu ...... tice guidelines (2nd edition).
@en
P2093
James R Jett
Kenneth A Kesler
Robert L Keith
Steven E Schild
P304
P356
10.1378/CHEST.07-1380
P407
P433
P577
2007-09-01T00:00:00Z